Clinical Trials
23 trialsNCT03955991 2025-06-26
VSMART
University of Miami
Phase 4 Completed
NCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed
NCT02860039 2024-10-22
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT03061955 2024-10-04
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
Wake Forest University Health Sciences
Completed
NCT02294487 2024-10-03
Study of the Immune Response After Vaccination in Multiple Myeloma Patients
Wake Forest University Health Sciences
Completed
NCT00965354 2024-09-19
MOSAIC
Imperial College London
Completed
NCT03644498 2024-01-18
Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells
Bristol-Myers Squibb
Completed
NCT02352389 2023-12-12
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents
St. Jude Children's Research Hospital
Completed
NCT01431326 2023-09-06
PTN_POPS
Duke University
Completed
NCT05818215 2023-04-18
Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
Pediatric Clinical Research Platform
Completed
NCT02108366 2019-10-21
Treatment of Severe Influenza A Infection
The University of Hong Kong
Phase 3 Completed
NCT03590808 2019-09-19
Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor
Seoul National University Hospital
Phase NA Completed
NCT02566265 2019-01-30
SHIVERING 2
Yale University
Phase 2 Completed
NCT00112112 2017-08-14
Safety Study to Evaluate FluMist in Immunocompromised Children
MedImmune LLC
Phase 1 Completed
NCT01205581 2016-09-23
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01666782 2016-06-24
IMMUNE
Rochester General Hospital
Phase 2 Completed
NCT00307177 2014-12-05
Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT01707628 2014-01-31
Rituxivac
St. Antonius Hospital
Phase NA Completed
NCT00828555 2012-10-16
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
Duke University
Completed
NCT01031719 2012-09-13
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Chiltern Pesquisa Clinica Ltda
Phase 3 Completed
NCT00307710 2012-07-31
Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00906750 2011-10-13
FMRESP
St. Jude Children's Research Hospital
Phase 1 Completed
NCT01016548 2010-06-04
Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
University Health Network, Toronto
Phase 3 Completed